Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Signal12 is dedicated to the discovery, development, and commercialization of first-in-class therapies for ophthalmic diseases. Founded by pharmaceutical industry veterans, the company was inspired by a pivotal moment when an urgent need for an innovative eye treatment led to the discovery of a unique forehead-based drug delivery approach. This breakthrough enabled effective delivery of progesterone, stabilizing ocular infecti...
Signal12 is dedicated to the discovery, development, and commercialization of first-in-class therapies for ophthalmic diseases. Founded by pharmaceutical industry veterans, the company was inspired by a pivotal moment when an urgent need for an innovative eye treatment led to the discovery of a unique forehead-based drug delivery approach. This breakthrough enabled effective delivery of progesterone, stabilizing ocular infections and shaping the development of Signal12’s flagship product, Pro-ocular™, offering a novel solution for ophthalmic care.

List your booth number for exhibitions, ask us